Olokizumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Olokizumab
Monoclonal antibody
Type Whole antibody
Source Humanized
Target IL6
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒N☑Y (what is this?)  (verify)

Olokizumab is an immunomodulator. It binds to interleukin 6.[1] Hence acting as an Anti-IL-6 therapeutic aimed at inflammatory disease e.g. rheumatoid arthritis (RA).

It had promising results in a phase II trial against placebo or tocilizumab for patients with moderate to severe RA.[2][3]

References[edit]